The First Phase 3 Trial of a New Drug Added to a Standard - Must use Triplet Therapy early in the diseases course - 101931

Spotlight
Video

The First Phase 3 Trial of a New Drug Added to a Standard - Must use Triplet Therapy early in the diseases course

ASHReport has 270 videos Subscribe Here

Loading........
Description: Keith Stewart, MD from Mayo Clinic Division of Hematology and Oncology discusses the first phase 3 trial of a new drug added to a standard and the must use triplet therapy early in the diseases course at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/23/18
Added : 11 months ago
Category : Multiple Myeloma